Ligand validation:6OPJ

PG4: TETRAETHYLENE GLYCOL

PG4 is a Ligand Of Interest in 6OPJ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6OPJ_PG4_A_608	22%	85%	0.206	0.821	0.5	0.24	-	-	0	0	100%	1
5DDF_PG4_A_603	77%	59%	0.1	0.939	0.63	0.93	-	1	0	0	100%	1
5DDB_PG4_A_604	67%	61%	0.114	0.924	0.71	0.74	-	1	0	0	100%	1
5DB0_PG4_A_601	58%	63%	0.12	0.9	0.45	0.94	-	-	0	0	100%	1
4OG6_PG4_A_603	52%	47%	0.126	0.885	0.76	1.28	-	2	1	0	100%	1
5DDD_PG4_A_609	41%	49%	0.193	0.908	0.68	1.28	-	2	1	0	100%	1
2PFX_PG4_A_192	99%	53%	0.053	0.98	0.83	0.98	1	1	1	0	100%	1
7RC4_PG4_A_405	98%	87%	0.058	0.979	0.09	0.59	-	-	0	0	100%	1
3DUR_PG4_B_112	96%	76%	0.067	0.978	0.47	0.46	-	-	0	0	100%	1
2BO0_PG4_A_1340	92%	40%	0.066	0.958	0.68	1.72	-	2	0	0	100%	1
7RC2_PG4_A_404	91%	90%	0.077	0.965	0.08	0.51	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.